Answers are grounded in this paper and cite their sources.
Hydrogen peroxide (H 2 O 2 )-generating enzymes (HGEs) are potentially useful for tumor therapy, but the potential is limited by the challenge in regulating H 2 O 2 production. Herein, we present site-specific in situ growth of a cationic polymer poly( N, N ′-dimethylamino-2-ethyl methacrylate) (PDMA) from the N-terminus of glucose oxidase (GOX) to generate a site-specific and cationic GOX–PDMA conjugate with well-retained activity and enhanced stability to regulate H 2 O 2 generation for cancer starvation and H 2 O 2 therapy. Notably, the efficiency of endocytosis of the conjugate was 4-fold higher than that of free GOX. As a result, relative to free GOX, the conjugate showed 1.5-fold increased cytotoxicity, 2-fold enhanced tumor retention, and 5-fold increased tolerability after intratumoral injection. Importantly, a single intratumoral injection of the conjugate completely abolished colon tumors without detectable side effects, whereas free GOX was ineffective and systemically toxic. This chemistry may provide a new, simple, general, and efficient solution to regulate H 2 O 2 production and thereby to dramatically improve the antitumor efficacy of HGEs while reducing side effects.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: